newsfilter
← Latest News
GlobeNewswire·

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update

Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as PresidentConnect's new management is currently evaluating the future clinical